Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:14 Issue:1 Number:5 ISSN#:2563-5476
RCT
ACE Report #13266
Ace Report Cover Physical Therapy & Rehab

No Clinical Benefit of High-Frequency Repetitive Transcranial Magnetic Stimulation for Fibromyalgia


How to Cite

OrthoEvidence. No Clinical Benefit of High-Frequency Repetitive Transcranial Magnetic Stimulation for Fibromyalgia. ACE Report. 2021;14(1):5. Available from: https://myorthoevidene.com/AceReport/Report/13266

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Effects of High-Frequency Neuronavigated Repetitive Transcranial Magnetic Stimulation in Fibromyalgia Syndrome: A Double-Blinded, Randomized Controlled Study

Am J Phys Med Rehabil. 2021 Feb 1;100(2): 138-146.

Contributing Authors: I Bilir A Askin I Sengul A Tosun

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Twenty patients diagnosed with fibromyalgia were randomized to receive 6 weeks of high-frequency neuro-navigated repetitive transcranial magnetic stimulation (rTMS) treatment (n=10) or sham treatment (n=10) for the improvement of pain. The primary outcome of interest was pain severity measured using a Visual Analogue Scale (VAS). Secondary outcomes of interest included stiffness measured on VAS, t...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE